Publicacións en colaboración con investigadores/as de Universidad de Zaragoza (19)

2018

  1. Heterozygous SSBP1 start loss mutation co-segregates with hearing loss and the m.1555A>G mtDNA variant in a large multigenerational family

    Brain, Vol. 141, Núm. 1, pp. 55-62

2014

  1. Regulation of mouse retroelement MuERV-L/MERVL expression by REX1 and epigenetic control of stem cell potency

    Frontiers in Oncology, Vol. 4 FEB

2013

  1. Functional analysis of rex1 during preimplantation development

    Stem Cells and Development, Vol. 22, Núm. 3, pp. 459-472

  2. Mitochondrial antibiograms in personalized medicine

    Human Molecular Genetics, Vol. 22, Núm. 6, pp. 1132-1139

  3. Stressed cybrids model demyelinated axons in multiple sclerosis

    Metabolic Brain Disease, Vol. 28, Núm. 4, pp. 639-645

2012

  1. Cybrids for mitochondrial DNA pharmacogenomics

    Drug Development Research, Vol. 73, Núm. 8, pp. 453-460

  2. Expression of endogenous retroviruses is negatively regulated by the pluripotency marker Rex1/Zfp42

    Nucleic Acids Research, Vol. 40, Núm. 18, pp. 8993-9007

  3. Oxidative phosphorylation differences between mitochondrial DNA haplogroups modify the risk of Leber's hereditary optic neuropathy

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1822, Núm. 8, pp. 1216-1222

  4. Read-through therapy for mitochondrial DNA nonsense mutations

    Drug Discovery Today

  5. Soy lecithin interferes with mitochondrial function in frozen-thawed ram spermatozoa

    Journal of Andrology, Vol. 33, Núm. 4, pp. 717-725

2011

  1. 'progress' renders detrimental an ancient mitochondrial DNA genetic variant

    Human Molecular Genetics, Vol. 20, Núm. 21, pp. 4224-4231

  2. Association of Rex-1 to target genes supports its interaction with Polycomb function

    Stem Cell Research, Vol. 7, Núm. 1, pp. 1-16

  3. Mitochondrial pharma-Q-genomics: Targeting the OXPHOS cytochrome b

    Drug Discovery Today

2010

  1. Mitochondrial pharmacogenomics: barcode for antibiotic therapy

    Drug Discovery Today, Vol. 15, Núm. 1-2, pp. 33-39

  2. Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups

    Human Molecular Genetics, Vol. 19, Núm. 17, pp. 3343-3353

2009

  1. Association of mitochondrial haplogroup J and mtDNA oxidative damage in two different North Spain elderly populations

    Biogerontology, Vol. 10, Núm. 4, pp. 435-442

  2. Diseases of the human mitochondrial oxidative phosphorylation system

    Advances in Experimental Medicine and Biology

  3. Moroccan mitochondrial genetic background suggests prehistoric human migrations across the Gibraltar Strait

    Mitochondrion, Vol. 9, Núm. 6, pp. 402-407

2008

  1. Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease

    Human Molecular Genetics, Vol. 17, Núm. 24, pp. 4001-4011